Ascentis® Express Phenyl-Hexyl, 2.7 μm HPLC Column
SUPELCO/53798-U - 2.7 μm particle size, L × I.D. 2 cm × 2.1 mm
Product Type: Equipment/Book
| agency | suitable for USP L11 |
| application(s) | food and beverages |
| feature | endcapped |
| impurities | <5 ppm metals |
| L × I.D. | 2 cm × 2.1 mm |
| manufacturer/tradename | Ascentis® |
| material | stainless steel column |
| matrix | Fused-Core particle platform |
| superficially porous particle | |
| matrix active group | phenylhexyl phase |
| packaging | 1 ea of |
| parameter | 60 °C temp. range |
| 600 bar max. pressure (9000 psi) | |
| particle size | 2.7 μm |
| pH range | 2-9 |
| pore size | 90 Å |
| product line | Ascentis® |
| Quality Level | 100  |
| separation technique | reversed phase |
| surface area | 135 m2/g |
| technique(s) | HPLC: suitable |
| LC/MS: suitable | |
| UHPLC-MS: suitable | |
| UHPLC: suitable |
| General description: | The Phenyl-Hexyl phase has unique selectivity arising from solute interaction with the aromatic ring and its delocalized electrons. It is complementary (orthogonal) to both C18 and RP-Amide phases because of this unique aromaticity. The Phenyl-Hexyl phase also tend to exhibit good shape selectivity, which may originate from solute multipoint interaction with the planar ring system. More retention and selectivity will often be observed for solutes with aromatic electron-withdrawing groups (fluorine, nitro, etc.) or with a delocalized heterocyclic ring system such as the benzodiazepine compounds. |
| Legal Information: | Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41115700 |